COVID-19: A Catalyst for Change for UK Clinical Oncology
- PMID: 32890533
- PMCID: PMC7462794
- DOI: 10.1016/j.ijrobp.2020.06.041
COVID-19: A Catalyst for Change for UK Clinical Oncology
Comment on
-
RECOVERY trial: the UK covid-19 study resetting expectations for clinical trials.BMJ. 2020 Apr 28;369:m1626. doi: 10.1136/bmj.m1626. BMJ. 2020. PMID: 32345591 No abstract available.
References
-
- Tait D. Radiation therapy in the United Kingdom and the wider role of the clinical oncologist. Int J Radiat Oncol Biol Phys. 2014;89:1–3. - PubMed
-
- Wilkinson E. RECOVERY trial: The UK covid-19 study resetting expectations for clinical trials. BMJ. 2020;369:m1626. - PubMed
-
- The Faculty of Clinical Oncology, the Royal College of Radiologists Specialty training curriculum for clinical oncology. https://www.rcr.ac.uk/sites/default/files/2016_curriculum_-_clinical_onc... Available at:
-
- National Institute for Health and Care Excellence COVID-19 rapid guideline: Delivery of radiotherapy. NICE guideline [NG162] https://www.nice.org.uk/guidance/NG162 Available at: - PubMed
-
- Lewis PJ, Roques TW. The response of the UK clinical oncology community to the COVID-19 pandemic [e-pub ahead of print]. Clin Oncol (R Coll Radiol).https://doi.org/10.1016/j.clon.2020.05.007. Accessed June 30, 2020. - DOI - PMC - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources